Select Page

Newsroom

Follow Our Journey On Social Media

Results Published In Leading Scientific Journals

Nature Biotechnology

An injectible nanoparticle generator enhances delivery of cancer therapeutics

Science Advances

Sequential deconstruction of composite drug transport in metastatic breast cancer

Nature Reviews Cancer

Approaches from the physical sciences can contribute to the rate at which powerful new diagnostic tools and therapies can be discovered. 

Breast Cancer Breakthrough

 

BrYet CEO Dr. Mauro Ferrari finds that an injectable nanoparticle generator enhances delivery of cancer therapeutics.

 

BrYet Partners With NerPharMa

 

BrYet US, Inc. starts a Manufacturing Development Agreement with NerPharMa for its lead product candidate ML-016 against lung and liver metastases from different type of breast cancer.

 

Panel: Nixon National Cancer Conference

 

BrYet CEO Dr. Mauro Ferrari discusses changing the future of cancer.

 

Pioneering Medical Advances with Silicon

BrYet is using silicon as the basis for innovative therapeutics at effective local concentrations with the fewest possible side effects.

Join Our Email List

Learn More About BrYet